This Month
Will Ozempic crush the junk-food business?
Developers inventing products for big food companies are trying to work out how to sell convenience food to those who suddenly crave fresh fruit.
- Tomas Weber
September
The doctor-turned-CEO aiming to beat Ozempic
Adam Steensberg leads Zealand Pharma, a Danish drug maker whose stock has risen by more than 800 per cent since he took over in 2022.
- Sara Sjolin
ASX hopeful Evolt 360 reveals plans to cash in on Ozempic boom
The founders of body scanning company are hoping to list on the stock market before Christmas, backed by investors including Regal, Soul Patts and Perennial.
- Tess Bennett
Novo Nordisk says new obesity pill reduces weight by 13.1pc
It says experimental pill Amycretin was safe and tolerable for patients in an early-stage trial, with mild-to-moderate side effects.
- Jacob Gronholt-Pedersen and Maggie Fick
July
The five best exercises to beat burnout and stress
Knowing what type of exercise to focus on when needed is key to allowing the stress chemicals to move through you more effectively.
- Boudicca Fox-Leonard
Are you overweight or obese? Depends on where you carry your fat
European experts have developed a new framework to modernise the staging, diagnosis and management of obesity.
- Jill Margo
June
Why that surprise weight gain might be an Ozempic baby
There is mounting evidence that weigh-loss drugs such as Ozempic are delivering baby-sized surprises.
- Updated
- Julie Hare
I tried the ‘Tesla’ of fasting diets. Here’s what happened
Valter Longo’s books about the benefits of abstaining from food have been bestsellers around the world, but the science to support his ideas is not conclusive.
- Agostino Petroni
How to dementia-proof your life in your 40s
Research shows that this decade plays a crucial role in predicting your future brain health – and nobody knows why.
- Charlotte Lytton
Three ways to start exercising outdoors – and stick to it
Hate the gym? There are clear benefits to spending time in nature, so here’s how to start exercising outside and stick with it.
- Albert Stumm
May
Do you have ‘portion distortion’? Here’s how big your dinner should be
Our appetites and waistlines have been growing at an alarming rate over the past few decades. Here’s how you can bring your dinners back under control.
- Emily Craig
Morgan Spurlock, ‘Super Size Me’ documentary director, dies at 53
The filmmaker’s career imploded after he acknowledged past incidents of sexual assault and harassment. The cause of his death was cancer.
- Brian Murphy
Men paid $760 to lose weight in ‘Game of Stones’ health scheme
A trial of a dieting program in which participants potentially lose money has been so successful that it will be rolled out nationally.
- Laura Donnelly
Are ultraprocessed foods unfairly vilified?
Many scientists suspect manufactured foods are causing a range of health issues, but there is a lack of rigorous research to prove it.
- Alice Callahan
March
Intermittent fasting may pose risks to your heart
A surprising new study has found that some intermittent fasters are more likely to die of heart disease.
- Updated
- Anahad O’Connor
Being overweight could depend on your parents
Having a parent who was obese in middle age trebles your odds of following suit, new research has found. With two such parents, you’re six times more likely to be obese.
- Jill Margo
The battle over the trillion-dollar weight-loss bonanza
Novo Nordisk and Eli Lilly are making blockbuster drugs. Can they maintain their lead?
- The Economist
‘A Mars bar in a yellow skin’: the truth about bananas
Is the popular fruit really such a health saviour? Here are the pros and cons of making bananas one of your five a day.
- Susanna Galton
February
I’ve got the ‘fat gene’ – but at 42 I’ve finally beaten it
Some of us are just genetically inclined to put on weight and keep it on. But that’s no reason for despair.
- Isabel Mohan
January
- Opinion
- Chanticleer
Why Australia’s biggest and oldest LIC defied the Ozempic sell-off
Australian Foundation Investment Company boss Mark Freeman says buying CSL and Resmed amid last year’s Ozempic rout was part of a tried-and-true strategy.
- James Thomson